Cargando…
Competing risks determining event-free survival in early breast cancer.
To evaluate the natural history of a disease and the effects of therapeutic interventions, it is important to determine which are the causes of treatment failure and to assess the extent to which each cause contributes to the total failure rate. The paper presents a new biostatistical technique to d...
Autores principales: | Arriagada, R., Rutqvist, L. E., Kramar, A., Johansson, H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1992
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977968/ https://www.ncbi.nlm.nih.gov/pubmed/1419642 |
Ejemplares similares
-
On the utility of the lognormal model for analysis of breast cancer survival in Sweden 1961-1973.
por: Rutqvist, L. E.
Publicado: (1985) -
Mortality by laterality of the primary tumour among 55,000 breast cancer patients from the Swedish Cancer Registry.
por: Rutqvist, L. E., et al.
Publicado: (1990) -
Immunohistochemical expression of the mucin-type glycoprotein A-80 and prognosis in human breast cancer.
por: Eriksson, E. T., et al.
Publicado: (1993) -
Dose- and time-response for breast cancer risk after radiation therapy for benign breast disease.
por: Mattsson, A., et al.
Publicado: (1995) -
Evaluating overall survival and competing risks of survival in patients with early‐stage breast cancer using a comprehensive nomogram
por: Xu, Yan‐Bo, et al.
Publicado: (2020)